Grove Biopharma

Prism BioLab

This company develops small molecule drug candidates using its proprietary protein-mimicry technology for pharmaceutical companies, biotechnology firms and researchers.

Think Bioscience

This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Biotheryx

The company develops protein degrader medicines for patients with cancer and inflammatory diseases.

General Proximity

This biotechnology platform develops induced-proximity medicines for pharmaceutical partners to target proteins associated with cancer, neurodegeneration and cardiometabolic diseases.

Arvinas

This biopharmaceutical company develops protein degradation therapies to treat patients with cancer and neurodegenerative diseases.

Generate Biomedicine

This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.

ProtOS

This company develops artificial intelligence models to design de-novo proteins for the degradation of undruggable targets for the pharmaceutical and medical biotechnology industries.